Core Insights - The article discusses the paradox of a surplus in the national medical insurance fund while pharmacies and hospitals face financial difficulties, attributing the issue to settlement and coordination problems within the system [2][12]. Group 1: Medical Insurance Fund Surplus - The national medical insurance fund has a surplus of nearly 3.9 trillion yuan, with an expected increase of 500 billion yuan in 2024, and Henan province alone has a surplus of 16.5 billion yuan for the year [2]. - Despite the surplus, many individuals experience difficulties with medical reimbursements, leading to a perception that the system is "stuck" [2]. Group 2: Pharmacy Challenges - Pharmacies in regions like Chongqing and Hubei prefer cash payments over insurance due to delays in receiving reimbursements from the medical insurance system, which can take up to three months in some areas [4][6]. - The operational costs for pharmacies, including rent and employee salaries, are pressing, and delayed reimbursements create cash flow issues, forcing them to encourage cash transactions [6][12]. Group 3: Hospital Financial Struggles - In 2024, 648 hospitals are reported to be in bankruptcy proceedings, highlighting severe financial distress in the healthcare sector [8]. - In New Xiang, three public hospitals faced significant issues, including the revocation of operating licenses and delayed salaries for medical staff, indicating a systemic problem in funding distribution [8][10]. Group 4: Systemic Issues in Medical Insurance - The slow settlement process and fragmented management of medical insurance across provinces contribute to the financial difficulties faced by pharmacies and hospitals [12][13]. - The profit margins for pharmacies have plummeted to 5.7%, with many pharmacies closing down due to unsustainable financial conditions [13]. Group 5: Proposed Solutions - The article suggests that implementing "immediate settlement" could alleviate cash flow issues, as demonstrated by Anhui province, which has significantly reduced reimbursement times [15]. - A nationwide coordination of medical insurance funds is proposed as a long-term solution to ensure equitable access to healthcare resources across regions, addressing the disparity between affluent and underfunded areas [17][19].

Core Viewpoint - The implementation of direct settlement between medical insurance and pharmaceutical companies has raised significant cash flow concerns for hospitals, as the new model alters the traditional payment cycle and may exacerbate existing financial pressures [1][3][5]. Group 1: Cash Flow Anxiety - Hospitals are experiencing heightened cash flow anxiety due to ongoing reforms in medical insurance payment methods and adjustments in medical service pricing, leading to reduced revenues and difficulties in payroll [2][5]. - The transition to direct settlement has caused hospitals to worry about the potential disruption of cash flow, which has historically been a crucial part of their financial stability [3][5]. - The average accounts receivable days for hospitals from pharmaceutical companies is reported to be 152 days, indicating a significant delay in cash inflow [6]. Group 2: Direct and Instant Settlement Policies - The direct settlement policy, which allows local medical insurance departments to settle payments with pharmaceutical companies directly, aims to shorten the payment cycle to within one month [1][3]. - The introduction of the prepayment system by the National Medical Insurance Administration in November 2024 is intended to alleviate cash flow pressures by allowing hospitals to apply for advance payments from the insurance fund [10][11]. - The prepayment system has been criticized for its stringent application requirements, making it difficult for hospitals to access these funds, which were previously more readily available under the old turnover fund system [11][12]. Group 3: Operational Adjustments in Hospitals - Hospitals are adjusting their procurement strategies due to cash flow constraints, often reducing inventory levels to avoid the risk of stockpiling unsold medications [8][10]. - The pressure to maintain timely payments to pharmaceutical companies has led some hospitals to consider taking loans to meet their obligations, which poses compliance risks [17]. - The implementation of daily or weekly settlement trials in some regions has been viewed positively by hospitals, as it provides more immediate cash flow without significantly increasing administrative burdens [25][24]. Group 4: Future Outlook - The goal of achieving instant settlement for medical insurance funds with designated medical institutions is set for 2025, with a target of 80% of regions implementing this by then [23]. - Concerns remain regarding the potential increase in operational workload for hospitals due to more frequent settlements, although initial feedback suggests that the benefits of improved cash flow outweigh these concerns [24][25].

Group 1 - The biopharmaceutical ETF (159657.SZ) has seen a 0.48% increase, with the associated index, Vaccine Biotech (980015.SZ), rising by 0.53% [1] - Major constituent stocks such as Changchun High-tech, Fosun Pharma, and Tigermed have shown positive performance, with increases of 1.11%, 0.88%, and 4.91% respectively [1] - The National Healthcare Security Administration reports that 77% of coordinated areas have achieved instant settlement between medical insurance and medical institutions, with a total of 300.1 billion yuan allocated to cover 361,800 designated medical institutions [1] Group 2 - Guotai Junan Securities indicates that the vaccine industry will experience a significant increase in inventory in 2024, influenced by demand fluctuations and channel inventory adjustments [2] - The overall sentiment in the vaccine sector is under pressure due to centralized procurement policies and regional political factors [2] - The industry strategy report from Guoxin Securities highlights that the NDA/IND applications for innovative drugs remain active, with progress on products like the HPV vaccine potentially supporting industry sentiment [2]